索特罗维马布:对抗SARS-CoV-2变种的疗效审查
Daniele Focosi1, Arturo Casadevall2, Massimo Franchini3
1North-Western Tuscany Blood Bank, Pisa University Hospital, via Paradisa 2, 56124 Pisa, Italy.
Viruses
|February 24, 2024
概括
抗斯派克单克隆抗体Sotrovimab在针对SARS-CoV-2变异时初步取得了成功,因为它准了保存的表位. 然而,免疫受损患者的病毒进化导致了耐药性和最终的退出.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 索特罗维马布是一种抗斯派克单克隆抗体 (mAb),是SARS-CoV-2的成功治疗方法.
- 它的有效性源于向高度保存的表位,提供抗病毒演变的弹性.
- 兴趣的BA.2.86*变种 (VOI) 的出现标志着其临床使用的初始限制.
研究的目的:
- 审查索特罗维马布对各种SARS-CoV-2变体的疗效.
- 讨论病毒演变和患者群体对索特罗维马布疗效的影响.
- 鉴于新出现的耐药性,评估继续使用索特罗维马布的理由.
主要方法:
- 随机对照试验 (RCT) 和真实世界的证据 (RWE) 对索特罗维马布疗效的审查.
- 分析SARS-CoV-2变种演变及其对抗体结合的影响.
- 检查不同患者群体中索特罗维马布的性能,包括免疫受损的个体.
主要成果:
- 索特罗维马布最初显示出有效性,但最终由于SARS-CoV-2变种而变得无效.
- 在免疫功能低下的个体中使用促进了抗体选择和病毒耐药性.
- 较新的变体缺乏与索特罗维马布的结合,质疑其持续的效用.
结论:
- 索特罗维马布的故事说明了治疗抗体和病毒进化之间的动态相互作用.
- 耐药性的出现强调了需要策略来缓解抗体耐药性的必要性.
- 持续推广索特罗维马布并没有得到当前证据对其对较新的变种无效的支持.
关键词:
这是S-309-309号.这就是SARS-CoV-2病毒.在VIR-783131中,您可以看到VIR-7831的位置.有效性 有效性 有效性.在安全方面,安全是安全的.这就是Sotrovimab.更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.8K
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.2K
相关概念视频
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
